Evolus Evolysse Comparable to Restylane-L in Dermal Filler Study

This episode covers Evolus, Inc.'s latest advancements with their submission of two new dermal fillers, Evolysse™ Lift and Evolysse™ Smooth, to the U.S. FDA. In a pivotal study, these products were tested against Restylane-L and showed promising results for treating nasolabial folds. Dr. Rui Avelar, Chief Medical Officer at Evolus, shares his optimism about the FDA approval process. The episode highlights the potential impact of these new treatments in the field of cosmetic dermatology.Stay c...